<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>219</id><JournalTitle>SOLID DISPERSION TECHNIQUES FOR ENHANCING SOLUBILITY OF POORLY WATER-SOLUBLE DRUGS</JournalTitle><Abstract>Poor aqueous solubility remains one of the major challenges in pharmaceutical formulation development, significantly
affecting the dissolution rate, absorption, and bioavailability of many therapeutic agents. Approximately 40–70% of newly
discovered drug candidates exhibit poor water solubility, leading to inadequate oral bioavailability and reduced therapeutic
efficacy. Among various solubility enhancement approaches, solid dispersion technology has emerged as an effective and
widely accepted strategy for improving the dissolution characteristics of poorly water-soluble drugs. Solid dispersions
involve the dispersion of one or more active pharmaceutical ingredients within an inert hydrophilic carrier matrix in the solid
state, resulting in enhanced wettability, reduced particle size, increased porosity, and conversion of crystalline drugs into
amorphous forms. Various types of solid dispersions, including eutectic mixtures, solid solutions, glass solutions, and
amorphous dispersions, have been developed using carriers such as polyethylene glycol, polyvinylpyrrolidone,
phospholipids, and cyclodextrins. Several preparation techniques including fusion, solvent evaporation, hot-melt extrusion,
lyophilization, electrospinning, and supercritical fluid technology have been successfully employed to formulate solid
dispersions. The technology has demonstrated significant potential in enhancing the bioavailability of Biopharmaceutical
Classification System (BCS) Class II and IV drugs. Despite challenges related to stability, scale-up, and manufacturing,
recent advancements in polymer science and processing technologies continue to expand the applicability of solid dispersions
in modern drug delivery. This review highlights the principles, classifications, preparation methods, mechanisms, advantages,
limitations, and recent developments in solid dispersion technology for improving the solubility and bioavailability of poorly
water-soluble drugs</Abstract><Email>lgopipharma10@gmail.com</Email><articletype>Research</articletype><volume>16</volume><issue>2</issue><year>2026</year><keyword>Poor aqueous solubility remains one of the major challenges in pharmaceutical formulation development, significantly affecting the dissolution rate, absorption, and bioavailability of many therapeutic agents. Approximately 40–70% of newly discovered drug </keyword><AUTHORS>Thulasiraman C,Dr. Kalvimoorthi V,Gopi L,Dr. Saravanan C</AUTHORS><afflication>M. Pharm, First Year, Department of Pharmaceutics, Aadhibhagawan College of Pharmacy, Rantham, Thiruvanamalai, Tamil Nadu, India,Professor, Cum Head Department of Pharmaceutics, Aadhibhagawan College of Pharmacy, Rantham, Thiruvanamalai, Tamil Nadu, India,Assistant Professor, Department of Pharmaceutics, Aadhibhagawan College of Pharmacy, Rantham, Thiruvanamalai, Tamil Nadu, India,Assistant Professor, Department of Pharmaceutics, Aadhibhagawan College of Pharmacy, Rantham, Thiruvanamalai, Tamil Nadu, India</afflication></Article></Articles>